ROCK SPRINGS CAPITAL MANAGEMENT LP Ultragenyx Pharmaceutical Inc. Transaction History

ROCK SPRINGS CAPITAL MANAGEMENT LP portfolio value:

$49.19M
portfolio value

ROCK SPRINGS CAPITAL MANAGEMENT LP quarter portfolio value change:

-30.59%
quarter

Ultragenyx Pharmaceutical Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +8.69% 94.96K shares -16.01M $41.41 1.18M
Q2 2022 share Increase +6.31% 64.92K shares -9.45M $59.66 1.09M
Q1 2022 share Increase +16.31% 144.18K shares 332K $72.62 1.02M
Q4 2021 share Increase +10.34% 82.81K shares 2.07M $84.25 883.92K
Q3 2021 share Increase +72.28% 336.10K shares 27.91M $90.19 801.10K
Q2 2021 share Increase +3.33% 15K shares -6.89M $95.35 465K
Q1 2021 share Decrease -20.56% -116.5K shares -27.18M $113.86 450K
Q4 2020 share Decrease -1.79% -10.34K shares 31.01M $138.43 566.5K
Q3 2020 share Decrease -10.82% -70K shares -3.18M $82.19 576.84K
Q2 2020 share Decrease -13.50% -100.95K shares 17.37M $78.22 646.84K
Q1 2020 share Increase +6.83% 47.8K shares 3.32M $44.43 747.8K
Q4 2019 share Increase +15.13% 92K shares 3.88M $42.71 700K
Q3 2019 share Increase +4.83% 28K shares -10.82M $42.78 608K
Q2 2019 share 0.00% 0 shares -3.39M $63.5 580K
Q1 2019 share Increase +36.47% 155K shares 21.75M $69.36 580K
Q4 2018 share Increase +112.50% 225K shares 3.21M $43.48 425K
Q3 2018 share 0.00% 0 shares -106K $76.34 200K
Q2 2018 share Increase +15.61% 27K shares 6.55M $76.87 200K
Q1 2018 share Increase +6.13% 10K shares 1.26M $50.99 173K
Q4 2017 share 0.00% 0 shares -1.12M $46.38 163K
Q3 2017 share Increase +1.56% 2.5K shares -1.28M $53.26 163K
Q2 2017 share Increase +0.47% 750 shares -859K $62.11 160.5K
Q1 2017 share 0.00% 0 shares -404K $67.78 159.75K
Q4 2016 share Increase +8.67% 12.75K shares 804K $70.31 159.75K
Q3 2016 share Increase +3.89% 5.5K shares 3.50M $70.94 147K
Q2 2016 share Increase +19.41% 23K shares -581K $48.91 141.5K
Q1 2016 share Increase +12.32% 13K shares -4.33M $63.31 118.5K